Bullish option flow detected in Crispr Therapeutics with 8,612 calls trading, 3x expected, and implied vol increasing over 9 points to 74.21%. May-24 60 calls and 4/26 weekly 60 calls are the most active options, with total volume in those strikes near 1,700 contracts. The Put/Call Ratio is 0.23. Earnings are expected on May 6th.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- CRISPR Therapeutics to Present at the Annual Needham Virtual Healthcare Conference
- Are Investors Vastly Underestimating CRISPR Therapeutics Stock (NASDAQ:CRSP)?
- Is Beam Therapeutics (NASDAQ:BEAM) Too Late to the Game?
- Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
- Crispr Therapeutics proposes to elect Christian Rommel to board of directors
